KALV
KalVista Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.00
+0.00%Leverage
- Debt / equity
- -104.83x
- Net debt / equity
- -20.24x
- Debt / assets
- 0.85x
- Debt / EBITDA
- -6.15x
- Net debt / EBITDA
- -1.19x
Liquidity & coverage
- Current ratio
- 5.58x
- Quick ratio
- 5.52x
- Cash ratio
- 5.23x
- Interest coverage
- -1.95x
- EBITDA / interest
- -1.47x
- Working capital
- $262.8M
Cash & dividend
- FCF / debt
- 0.12x
- Cash flow / debt
- 0.13x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026